Jones Financial Companies
CABA icon

Jones Financial Companies’s Cabaletta Bio CABA Stock Holding History

Jones Financial Companies’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Buy
3,997
+3,344
+512% +$11K ﹤0.01% 3719
2026
Q1 		$1.75K Sell
653
-20,007
-97% -$55.6K ﹤0.01% 4186
2025
Q4 		$45.2K Buy
20,660
+653
+3% +$1.62K ﹤0.01% 2574
2025
Q3 		$47.2K Buy
+20,007
New +$34.3K ﹤0.01% 2405
2025
Q2 		– Sell
-18,507
Closed -$28.7K – 4046
2025
Q1 		$28.7K Buy
18,507
+14,897
+413% +$31.7K ﹤0.01% 2291
2024
Q4 		$8.2K Buy
+3,610
New +$12.7K ﹤0.01% 2596

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jones Financial Companies's CABA Position: Q2 2026 in Review

Jones Financial Companies increased its Cabaletta Bio (CABA) stake by 512% in Q2 2026, buying an estimated $11K and bringing the position to 3,997 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3719.

Jones Financial Companies first reported a position in CABA in Q4 2024 and has held it in 6 quarters since. The position peaked at $47.2K in Q3 2025. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Jones Financial Companies held 3,997 shares of Cabaletta Bio worth $12.2K as of Q2 2026.
  • Jones Financial Companies bought 3,344 Cabaletta Bio shares in Q2 2026, an estimated $11K.
  • Cabaletta Bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3719 holding.
  • Jones Financial Companies first reported a position in Cabaletta Bio in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's Cabaletta Bio position peaked at $47.2K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.